The tuberculosis treatment success rate for newly treated cases in the UK is forecasted to plateau at 79% from 2024 to 2028, indicating no improvement from 2023 levels. This consistency suggests a stable yet stagnant outlook in the effectiveness of TB treatment over the next five years.

Looking beyond the forecast, certain trends should be observed:

Potential impact of new medical technologies or drug developments on treatment success.
Changes in health policy or funding that might affect resources available for TB treatment.
Overall healthcare system adaptations to emerging issues, such as antibiotic resistance.